IAG Appoints Dr. Christophe Berthoux a Chairman to the Board

Image Analysis Group, a global leader in medical imaging solutions for drug development, has announced the appointment of Dr. Christophe Berthoux as Chairman to the Board, marking a significant milestone in the company’s global expansion strategy.

With a presence in 32 countries and offices across the US, Singapore, Netherlands, Nigeria, and the UK, IAG has established itself as a major international player in the clinical trials industry. The company’s global reach is reflected in its sales, with 65% of revenue coming from outside the UK, and the United States emerging as its fastest-growing region due to the rapid adoption of AI technologies.

Dr. Berthoux, who joined IAG to develop the company’s growth strategies, brings 28 years of experience in the clinical research industry. His appointment aligns with IAG’s vision to accelerate its expansion across all stages of the drug development process through innovative technologies and world-class operations.

IAG’s scale is evident in its track record of delivering over 700 successful clinical trials since 2007. The company’s proprietary cloud-based platform, DYNAMIKA, has been instrumental in streamlining operations and facilitating central review for multi-center trials across the globe.

Dr. Olga Kubassova, IAG’s founder and now President, emphasized the strategic importance of Dr. Berthoux’s appointment, stating, “Christophe’s extensive experience in leading global commercial teams and international business growth will be incredibly beneficial to IAG, as we look to drive successful growth and international expansion.”

As IAG continues to expand its global footprint, the company remains committed to improving patient outcomes by delivering better, faster clinical trials through its responsive customer service, proprietary technology platform DYNAMIKA, worldwide operations, and medical imaging